Canada markets close in 4 minutes

BeiGene, Ltd. (BGNE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
217.94-3.81 (-1.72%)
As of 03:55PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close221.75
Open221.85
Bid217.40 x 800
Ask218.02 x 900
Day's Range215.81 - 222.60
52 Week Range118.18 - 280.62
Volume157,691
Avg. Volume234,295
Market Cap48.681B
Beta (5Y Monthly)0.76
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
  • Business Wire

    BeiGene Appoints Julius Pryor III as First Global Head of Diversity and Health Equity

    BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass., March 30, 2023--BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced the appointment of Julius Pryor III as its first Global Head of Diversity and Health Equity, effective immediately.

  • Business Wire

    BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint in New Jersey

    BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass., March 21, 2023--BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, is entering a new phase as it continues to build its U.S. presence. The company announced today that the last piece of structural steel will be laid at its Hopewell, NJ campus today. This new facility will provide state-of-the-art commercial-stage U.S. biologic pharmaceutical manufacturing, late-stage research and clinical development capabilities tha

  • Business Wire

    BeiGene Reports Fourth Quarter and Full Year 2022 Financial Results

    BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass., February 27, 2023--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today reported financial results for the fourth quarter and full year 2022, recent business highlights, and upcoming milestones.